Fluticasone Propionate NDC 45802-221

NDC codes

FDA NDC Directory

Product NDC (as listed)45802-221Labeler and product segments. Claims need a package NDC.

Product NDC at billing width45802-0221Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
45802-221-11	45802022111	1 TUBE in 1 CARTON (45802-221-11) / 30 g in 1 TUBEMarketed from Jul 9, 2007
45802-221-35	45802022135	1 TUBE in 1 CARTON (45802-221-35) / 15 g in 1 TUBEMarketed from Feb 12, 2008
45802-221-37	45802022137	1 TUBE in 1 CARTON (45802-221-37) / 60 g in 1 TUBEMarketed from Oct 31, 2007

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Fluticasone Propionate
Generic name (nonproprietary): fluticasone propionate
Active ingredients: Fluticasone propionate — .05 mg/g
Dosage form: Ointment
Route: Topical
Labeler: Padagis Israel Pharmaceuticals Ltd
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 076668
Marketing start: Jul 9, 2007
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 45802-221_d4ab6f31-add7-41ec-912f-ae64bd61975eSPL ID d4ab6f31-add7-41ec-912f-ae64bd61975eSPL set ID 16985600-3f81-4d51-8bf7-0cbbd89856a1RxCUI 895487UNII O2GMZ0LF5W
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N445802022111 followed by a unit qualifier and the quantity

Package 45802-0221-11. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 30, 2023.

Indications (excerpt from the label)

Fluticasone propionate ointment is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in adult patients. Fluticasone propionate ointment is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in adult patients. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 076668

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 076668
Product	Strength	Form · route	Labeler	Product NDC
Fluticasone Propionate	Fluticasone propionate .05 mg/g	OintmentTopical	Bryant Ranch Prepack	72162-1401
Fluticasone Propionate	Fluticasone propionate .05 mg/g	OintmentTopical	Bryant Ranch Prepack	63629-8662
Fluticasone Propionate	Fluticasone propionate .05 mg/g	OintmentTopical	Bryant Ranch Prepack	63629-8661
Fluticasone Propionate	Fluticasone propionate .05 mg/g	OintmentTopical	Bryant Ranch Prepack	63629-8663